European allergen immunotherapy manufacturer focused on respiratory and food allergies
HAL Allergy manufactures modified allergen extracts for immunotherapy across Europe, operating from Leiden with 200+ specialized staff. The tech stack reveals a heavily regulated pharma operation: Labware LIMS for lab data, SAP SuccessFactors + Workday for HR, SQL Server + Azure for infrastructure, and Power BI for reporting. Active adoption of Power Automate signals a push toward process automation—consistent with their stated focus on automation initiatives and process redesign. Hiring is accelerating across quality, sales, and security roles, while pain points around batch release timing, cloud security in hybrid environments, and HR operational complexity suggest they're scaling compliance and ops infrastructure simultaneously.
HAL Allergy develops, manufactures, and distributes allergen immunotherapies for treatment and prevention of allergic diseases, with expertise in respiratory and food allergies. Based in Leiden Bio Science Park, Netherlands, the company operates as a privately held manufacturer serving European markets. Their product portfolio centers on modified allergen extracts for both therapeutic and diagnostic purposes. The organization spans more than 300 highly specialized employees across manufacturing, quality assurance, sales, HR, data, and security functions. Current operational priorities include international expansion, business continuity hardening, system modernization, and strengthening sales capacity.
HAL Allergy uses Labware LIMS for lab operations, SAP SuccessFactors and Workday for HR, SQL Server and Azure for infrastructure, Power BI for analytics, and Microsoft Office 365 suite. They are actively adopting Power Automate for process automation.
HAL Allergy is headquartered in Leiden, Netherlands, specifically in the Leiden Bio Science Park, where they focus on development and manufacturing of allergen extracts.
Other companies in the same industry, closest in size